Gastroenterology Research and Practice / 2019 / Article / Fig 3

Research Article

Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study

Figure 3

Multivariate stratified analyses for the association between ACEi/ARB or CCB therapy and ESRD risk in patients with liver cirrhosis. ACEi: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; COX-2: cyclooxygenase-2 inhibitor; CI: confidence interval; HR: hazard ratio; HBV: patients with hepatitis B virus infection; HCV: patients with hepatitis C virus infection; NSAID: nonsteroidal anti-inflammatory drug.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.